Blogs

Early publication of patent application under the Indian patent law system

19th April, 2017 - 3:45 am Categories: India Intellectual Property News & Updates Patents

Publication of a patent application is one of the prime stages in the process of getting a patent. The publication date of the patent application is considered of a specific significance because the applicants’ advantages as well as rights start from the publication date. Even though the applicant cannot seek any infringement proceedings till the … Continue reading Early publication of patent application under the Indian patent law system

Read more »

Injunction against Cipla COPD Drug ‘INDAFLO’ Upheld: Delhi High Court

14th April, 2017 - 6:30 am Categories: Legal Issues pharma

Reportedly, on an appeal filed by Cipla pertaining to COPD drug INDAFLO, the Delhi High court division bench maintained the interim injunction imposed by single judge against Cipla. As per the order, Cipla has now been restrained from, inter alia, using, manufacturing, importing, selling any pharmaceutical products etc. containing ‘INDACATEROL‘ or ‘INDACATEROL Maleate‘, alone or … Continue reading Injunction against Cipla COPD Drug ‘INDAFLO’ Upheld: Delhi High Court

Read more »

Hidden Figures: Panasonics’s Invisible Television

10th April, 2017 - 6:33 am Categories: News & Updates Technology

Entertainment has had various developmental dimensions in each decade. From sitting under the sky and watching plays in person, to the same developing as a career. Then we evolved the idea of television, channelizing frequencies to look at people on a screen. Being black and white initially, we have seen added colours, LCD and LED … Continue reading Hidden Figures: Panasonics’s Invisible Television

Read more »

Delhi High Court sought Explanation through Counter Affidavit over Repudiation of Patent application for Xtandi

8th April, 2017 - 6:11 am Categories: India Intellectual Property IP Practice in India News & Updates Patents

Xtandi, the wonder drug for prostate cancer, was developed at UCLA, Los Angeles, by the innovation of NIH and Department of Defense grants. The drug was later licensed to Medivation, a biopharma company, which in October 2009 struck a deal with Japanese Astellas Pharma to collaborate on developing and commercializing Xtandi. The two companies now … Continue reading Delhi High Court sought Explanation through Counter Affidavit over Repudiation of Patent application for Xtandi

Read more »

Nuziveedu seeds wins legal battle against US Giant Monsanto!

5th April, 2017 - 4:08 am Categories: Intellectual Property Licensing News & Updates Patents

It has been a long time since M. Prabhakara Rao, the chairman of Nuziveedu Seeds, was trying to knock down the world’s largest seed company “Monsanto Co”, in a high-profile conflict over licensing and royalty of patented seed technology–Bollgard II. Finally, in a decision taken on 29th of March, M. Prabhakara Rao won the long-fought … Continue reading Nuziveedu seeds wins legal battle against US Giant Monsanto!

Read more »

Samsung Patent Licensing Agreement with Personalized Media Communications

25th March, 2017 - 11:47 am Categories: Intellectual Property IP Commercialization IP Licensing Licensing Patent Commercialisation Patent Licensing

Texas-based Personalized Media communications, which is having a seminal intellectual property portfolio, has successfully signed a patent licensing agreement with Samsung Corporation and its affiliates. PMC patent portfolio includes around 100 issued patents and pending applications that cover the use of control and information signals to control automated systems for generating and delivering electronic content … Continue reading Samsung Patent Licensing Agreement with Personalized Media Communications

Read more »

Meizu – Qualcomm License Agreement Deal

25th March, 2017 - 11:44 am Categories: Intellectual Property IP Commercialization IP Licensing Licensing Patent Commercialisation Patent Licensing

Qualcomm and the Chinese consumer electronics company Meizu recently announced that they had signed a licensing deal with each other. With this deal, they ended a yearlong infringement suit which was filed by Qualcomm against the Chinese company. In the October of 2016, we came to know that Qualcomm (the largest chipmaker in the world) … Continue reading Meizu – Qualcomm License Agreement Deal

Read more »

BlackBerry and India’s Optiemus Infracom sign’s licensing agreement to capture Asian smartphone market

25th March, 2017 - 11:43 am Categories: Intellectual Property IP Commercialization IP Licensing Licensing Patent Licensing

BlackBerry once a phone innovator, was considered a game changer in 1999 when its mobile phone allowed on-the-go business people to access email wirelessly. BlackBerry devices were popular for a long time almost a decade. But with the introduction of the iPhone in 2007 and Google’s android in 2008 BlackBerry lost its market as a … Continue reading BlackBerry and India’s Optiemus Infracom sign’s licensing agreement to capture Asian smartphone market

Read more »

Khurana & Khurana expands footprint in South East Asia

24th March, 2017 - 5:39 am Categories: Copyright Design IP Litigation NEPAL News & Updates Patents Trademark

With business models over the world turning more idea-driven, Intellectual Property Rights (IPRs) are now one of the most valuable assets for any economy. With a significant increase in IPR related activities, South East Asia is developing as a key market for IP Protection and initiating Enforcement actions. Khurana & Khurana, Advocates and IP Attorneys … Continue reading Khurana & Khurana expands footprint in South East Asia

Read more »

Fighting with Counterfeit Menace: Montblanc Simplo GmbH vs. Gaurav Bhatia & ors. CS(OS) 2563/2013: Granting Injunctive Relief

21st March, 2017 - 7:38 am Categories: India IP Practice in India News & Updates Trademark

Introduction: It always has been a well known fact that the markets in India are targeted by large number of counterfeit products/goods. Popular brands like LV, GUCCI, Burberry, Armani, Hermes inter alia; are frequently pirated in local commercial markets. Among others, the most popular counterfeit products in market include hardware, software, clothing, watches, writing instruments. … Continue reading Fighting with Counterfeit Menace: Montblanc Simplo GmbH vs. Gaurav Bhatia & ors. CS(OS) 2563/2013: Granting Injunctive Relief

Read more »

Categories

Archives